AEMD
NASDAQ HealthcareAethlon Medical, Inc. - Common Stock
Medical Devices
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
๐ Market Data
| Price | $6.31 |
|---|---|
| Volume | 2,446,696 |
| Market Cap | 4.49M |
| Beta | 1.400 |
| RSI (14-Day) | 82.3 Overbought |
| 200-Day MA | $9.19 |
| 50-Day MA | $2.74 |
| 52-Week High | $41.50 |
| 52-Week Low | $1.41 |
| Forward P/E | -11.07 |
| Price / Book | 0.58 |
๐ฏ Investment Strategy Scores
AEMD scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (98/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ฐ Dividend Daddy (16/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find AEMD in your text
Paste any article, transcript, or post โ the tool will extract AEMD and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-09-18.